A 52-year-old woman with obesity: Review of bariatric surgery

JAMA

Volumn 302, Issue 10, 2009, Pages 1097-1104

  Wee, Christina C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; LEVOTHYROXINE; LISINOPRIL; NAPROXEN;

ADULT; ANAMNESIS; ANXIETY DISORDER; BARIATRIC SURGERY; BODY MASS; CASE REPORT; COMORBIDITY; DEPRESSION; EPIDEMIOLOGICAL DATA; FEMALE; GASTRIC BANDING; HUMAN; KNEE ARTHROSCOPY; MORTALITY; OBESITY; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK FACTOR; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL RISK; TREATMENT OUTCOME; WEIGHT REDUCTION; ANXIETY; ARTICLE; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; GASTROPLASTY; MIDDLE AGED;

ANXIETY; COMORBIDITY; DEPRESSION; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HUMANS; MIDDLE AGED; OBESITY; QUALITY OF LIFE; WEIGHT LOSS;

EID: 70149120139     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1197     Document Type: Review

References (68)

1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report: National Institutes of Health. Obes Res. 1998;6(suppl 2):51S-209S.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295(13):1549-1555.
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238-1245.
4. Gregg EW, Cheng YJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293 (15):1868-1874. (Pubitemid 40548183)
5. Li Z, Bowerman S, Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am. 2005;85(4):681-701.
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625-1638. (Pubitemid 36459468)
7. Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res. 2001; 9(12):788-805.
8. White MA, O'Neil PM, Kolotkin RL, Byrne TK. Gender, race, and obesity-related quality of life at extreme levels of obesity. Obes Res. 2004;12(6):949-955.
9. Finkelstein EA, Trogdon JG, Brown DS, Allaire BT, Dellea PS, Kamal-Bahl SJ. The lifetime medical cost burden of overweight and obesity: implications for obesity prevention. Obesity (Silver Spring). 2008;16(8):1843-1848.
10. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med. 1993;329(14):1008-1012. (Pubitemid 23307910)
11. Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med. 2000;132(9):697-704. (Pubitemid 30244168)
12. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med. 2004;19(4):332-338. (Pubitemid 38530504)
13. Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening. J Gen Intern Med. 2004;19(4):324-331.
14. Wee CC, Phillips RS, McCarthy EP. BMI and cervical cancer screening among white, African-American, and Hispanic women in the United States. Obes Res. 2005;13(7):1275-1280.
15. Sjöström L, Lindroos AK, Peltonen M, et al; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-2693.
16. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
17. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998; 158(17):1855-1867. (Pubitemid 28440858)
18. McMahon FG, Fujioka K, Singh BN, et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2000;160(14): 2185-2191. (Pubitemid 30482726)
19. Rössner S, Sjöström L, Noack R, Meinders AE, Noseda G; European Orlistat Obesity Study Group. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res. 2000;8(1):49-61.
20. US Preventive Services Task Force. Screening for obesity in adults: recommendations and rationale. Ann Intern Med. 2003;139(11):930-932.
21. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579-584.
22. Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med. 2004;164(9):994-1003. (Pubitemid 38581520)
23. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142(7):532-546.
24. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999;281(3):235-242. (Pubitemid 29058112)
25. Belle SH, Berk PD, Courcoulas AP, et al; Longitudinal Assessment of Bariatric Surgery Consortium Writing Group. Safety and efficacy of bariatric surgery: longitudinal assessment of bariatric surgery. Surg Obes Relat Dis. 2007;3(2):116-126.
26. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health. 2007;121(7):492-496.
27. Encinosa WE, Bernard DM, Chen CC, Steiner CA. Healthcare utilization and outcomes after bariatric surgery. Med Care. 2006;44(8):706-712. (Pubitemid 44284260)
28. Nguyen NT, Paya M, Stevens CM, Mavandadi S, Zainabadi K, Wilson SE. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg. 2004;240(4):586-593. (Pubitemid 39281281)
29. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132(6):2253-2271.
30. Tucker ON, Szomstein S, Rosenthal RJ. Nutritional consequences of weightloss surgery. Med Clin North Am. 2007;91(3):499-514.
31. Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):127-132. (Pubitemid 46444696)
32. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008; 299(3):316-323. (Pubitemid 351159368)
33. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized controlled trial. Ann Intern Med. 2006;144(9):625-633. (Pubitemid 46780646)
34. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547-559.
35. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-1737. (Pubitemid 39346675)
36. Weber M, Muller MK, Bucher T, et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg. 2004; 240(6):975-982, discussion 982-983.
37. Favretti F, Segato G, Ashton D, et al. Laparoscopic adjustable gastric banding in 1791 consecutive obese patients: 12-year results. Obes Surg. 2007;17(2): 168-175. (Pubitemid 47091577)
38. Alger-Mayer S, Rosati C, Polimeni JM, Malone M. Preoperative binge eating status and gastric bypass surgery: a long-term outcome study. Obes Surg. 2009; 19(2):139-145.
39. Averbukh Y, Heshka S, El-Shoreya H, et al. Depression score predicts weight loss following Roux-en-Y gastric bypass. Obes Surg. 2003;13(6):833-836. (Pubitemid 38010699)
40. Sallet PC, Sallet JA, Dixon JB, et al. Eating behavior as a prognostic factor for weight loss after gastric bypass. Obes Surg. 2007;17(4):445-451. (Pubitemid 46850180)
41. Alvarado R, Alami RS, Hsu G, et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2005; 15(9):1282-1286. (Pubitemid 41565127)
42. Evans RK, Bond DS, Wolfe LG, et al. Participation in 150 min/wk of moderate or higher intensity physical activity yields greater weight loss after gastric bypass surgery. Surg Obes Relat Dis. 2007;3(5):526-530.
43. Tarnoff M, Kaplan LM, Shikora S. An evidenced-based assessment of preoperative weight loss in bariatric surgery. Obes Surg. 2008;18(9):1059-1061.
44. Mrad BA, Stoklossa CJ, Birch DW. Does preoperative weight loss predict success following surgery for morbid obesity? Am J Surg. 2008;195(5):570-573.
45. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396-1402.
46. Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008;31(11):516-520.
47. Saber AA, Boros MJ, Mancl T, Elgamal MH, Song S, Wisadrattanapong T. The effect of laparoscopic Roux-en-Y gastric bypass on fibromyalgia. Obes Surg. 2008; 18(6):652-655.
48. Flum DR, Belle SH, King WC, et al; Longitudinal Assessment of Bariatric Surgery Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445-454.
49. Ballantyne GH, Ewing D, Capella RF, et al. The learning curve measured by operating times for laparoscopic and open gastric bypass: roles of surgeon's experience, institutional experience, body mass index and fellowship training. Obes Surg. 2005;15(2):172-182. (Pubitemid 40315999)
50. Kelly JJ, Shikora S, Jones DB, et al. Best practice updates for surgical care in weight loss surgery. Obesity (Silver Spring). 2009;17(5):863-870.
51. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population- based analysis. J Am Coll Surg. 2004;199(4):543-551.
52. Branson R, Potoczna N, Brunotte R, et al. Impact of age, sex and body mass index on outcomes at four years after gastric banding. Obes Surg. 2005;15 (6):834-842. (Pubitemid 40904875)
53. Jamal MK, DeMaria EJ, Johnson JM, et al. Impact of major co-morbidities on mortality and complications after gastric bypass. Surg Obes Relat Dis. 2005; 1(6):511-516.
54. DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3(2):134-140. (Pubitemid 46444703)
55. Flum DR, Salem L, Elrod JA, Dellinger EP, Cheadle A, Chan L. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005; 294(15):1903-1908. (Pubitemid 41464691)
56. Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA. 2005;294(15):1918-1924.
57. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-752. (Pubitemid 47295641)
58. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-761. (Pubitemid 47295642)
59. van Hout GC, Boekestein P, Fortuin FA, Pelle AJ, van Heck GL. Psychosocial functioning following bariatric surgery. Obes Surg. 2006;16(6):787-794. (Pubitemid 43874840)
60. Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obes Surg. 2003;13(6):954-964.
61. Herpertz S, Kielmann R, Wolf AM, Langkafel M, Senf W, Hebebrand J. Does obesity surgery improve psychosocial functioning? a systematic review. Int J Obes Relat Metab Disord. 2003;27(11):1300-1314. (Pubitemid 37386477)
62. Peace K, Dyne J, Russell G, Stewart R. Psychobiological effects of gastric restriction surgery for morbid obesity. N Z Med J. 1989;102(862):76-78. (Pubitemid 19112070)
63. Wagner AJ, Fabry JM Jr, Thirlby RC. Return to work after gastric bypass in Medicaid-funded morbidly obese patients. Arch Surg. 2007;142(10):935-940. (Pubitemid 47607599)
64. Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS Intervention Study. Int J Obes (Lond). 2007;31(8):1248-1261. (Pubitemid 47172616)
65. Gusenoff JA, Messing S, O'Malley W, Langstein HN. Temporal and demographic factors influencing the desire for plastic surgery after gastric bypass surgery. Plast Reconstr Surg. 2008;121(6):2120-2126.
66. Greenberg I, Sogg S, Perna FM. Behavioral and psychological care in weight loss surgery: best practice update. Obesity (Silver Spring). 2009;17(5):880-884.
67. Wee CC, Pratt JS, Fanelli R, Samour PQ, Trainor LS, Paasche-Orlow MK. Best practice updates for informed consent and patient education in weight loss surgery. Obesity (Silver Spring). 2009;17(5):885-888.
68. Apovian CM, Cummings S, Anderson W, et al. Best practice updates for multidisciplinary care in weight loss surgery. Obesity (Silver Spring). 2009;17(5): 871-879.